With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
The rising popularity of randomized controlled trials (RCTs) in development applications has come with continuing debates about the merits of this approach. The paper takes stock of the issues. While RCTs have an important place in the toolkit for impact evaluation, an unconditional preference for RCTs as the “gold standard” is questionable on three main counts. First, the case for such a preference is unclear on a priori grounds; indeed, for a given budget, even a biased observational study may well come closer to the truth than an RCT. Second, the ethical objections to RCTs call for a stronger defense than is commonly found at present. Third, there is a serious risk of distorting the evidence-base for informing development policymaking, given that an insistence on doing RCTs generates selection bias in what gets evaluated. Going forward, pressing knowledge gaps should drive the questions asked and how they are answered, not the methodological preferences of some researchers. The gold standard is the best method for the question at hand.
Click here for the previous (August 2018) version of this paper.
Rights & Permissions
You may use and disseminate CGD’s publications under these conditions.